A single study by Modali et al. [74] has identified a potential role for the lncRNA MEG3 in insulinomas: MEG3 acts as a tumor suppressor in different cancers [75], and loss of function is associated with decreased control over cell proliferation. This evidence concerns the gene MEG3 and cancer.